These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 7565956)
21. Treatment of reflux esophagitis with H2-blockers, antacids and prokinetic drugs. An analysis of randomized clinical trials. Koelz HR Scand J Gastroenterol Suppl; 1989; 156():25-36. PubMed ID: 2568015 [TBL] [Abstract][Full Text] [Related]
22. [Effect of oxmetidine and ranitidine on reflux behavior in patients with esophagitis]. Weiser HF; Gubernatis G; Siewert JR Z Gastroenterol; 1983 Oct; 21(10):580-4. PubMed ID: 6139923 [TBL] [Abstract][Full Text] [Related]
23. Medical treatments in the short-term management of reflux esophagitis. Guirguis-Blake J Am Fam Physician; 2008 Mar; 77(5):620. PubMed ID: 18350759 [No Abstract] [Full Text] [Related]
24. A comparison of five maintenance therapies for reflux esophagitis. Vigneri S; Termini R; Leandro G; Badalamenti S; Pantalena M; Savarino V; Di Mario F; Battaglia G; Mela GS; Pilotto A N Engl J Med; 1995 Oct; 333(17):1106-10. PubMed ID: 7565948 [TBL] [Abstract][Full Text] [Related]
25. Omeprazole in infants with cimetidine-resistant peptic esophagitis. Alliët P; Raes M; Bruneel E; Gillis P J Pediatr; 1998 Feb; 132(2):352-4. PubMed ID: 9506656 [TBL] [Abstract][Full Text] [Related]
26. [Conservative therapy of reflux esophagitis]. Koop H Z Gastroenterol Verh; 1990 Apr; 25():135-7. PubMed ID: 1694350 [No Abstract] [Full Text] [Related]
28. The outcome of reflux oesophagitis: does drug-induced remission mean cure? Savarino V; Celle G Ital J Gastroenterol Hepatol; 1998 Oct; 30(5):475-7. PubMed ID: 9836098 [No Abstract] [Full Text] [Related]
32. [Drug therapy of ulcer and reflux esophagitis. Recommendations from a group of experts]. Lakartidningen; 1993 Jul; 90(28-29):2530-2. PubMed ID: 8326797 [No Abstract] [Full Text] [Related]
33. [Acid reflux on the esophagus. What helps in acute reflux esophagitis, how to prevent a recurrence?]. Mörk H MMW Fortschr Med; 2000 Apr; 142(17):26-9. PubMed ID: 10879017 [TBL] [Abstract][Full Text] [Related]
34. Factors influencing corpus argyrophil cell density and hyperplasia in reflux esophagitis patients treated with antisecretory drugs and controls. Diebold MD; Richardson S; Duchateau A; Bigard MA; Colin R; Cortot A; Fauchère JL; Zeitoun P Dig Dis Sci; 1998 Aug; 43(8):1629-35. PubMed ID: 9724142 [TBL] [Abstract][Full Text] [Related]
36. [Long-term drug therapy of ulcer disease. Findings for deciding, indications, duration and surgical alternatives]. Peitsch W Fortschr Med; 1986 Sep; 104(36):681-4. PubMed ID: 2876940 [No Abstract] [Full Text] [Related]
37. Long-term management of gastroesophageal reflux disease and its complications. Richter JE Am J Gastroenterol; 1997 Apr; 92(4 Suppl):30S-34S; discussion 34S-35S. PubMed ID: 9127624 [TBL] [Abstract][Full Text] [Related]
38. [Current concepts in therapy of reflux disease]. Kirchgatterer A; Aschl G; Hinterreiter M; Stadler B; Knoflach P Wien Med Wochenschr; 2001; 151(11-12):266-9. PubMed ID: 11515224 [TBL] [Abstract][Full Text] [Related]
39. [Treatment of reflux esophagitis with ranitidine. A multicentric prospective study]. Koelz HR; Birchler R; Bron B; Delmore G; Frey M; Gonvers JJ; Halter F; Hammer B; Miller G; Realini S; Blum AL Schweiz Med Wochenschr; 1982 Dec; 112(51):1901-4. PubMed ID: 6298933 [TBL] [Abstract][Full Text] [Related]